Red Sea Bream Iridovirus
Taxonomy and Classification of Red Sea Bream Iridovirus
Red sea bream iridovirus (RSIV) is a member of the family Iridoviridae, a group of large, double-stranded DNA viruses that infect a diverse range of invertebrate and ectothermic vertebrate hosts. Within this family, RSIV is assigned to the genus Megalocytivirus, a lineage defined by its characteristic formation of cytoplasmic viral assembly sites and the production of enlarged, inclusion body-bearing cells (IBCs) in infected tissues [19, 20]. The genus Megalocytivirus currently comprises three major clades, infectious spleen and kidney necrosis virus (ISKNV), turbot reddish body iridovirus (TRBIV), and red sea bream iridovirus (RSIV), each originally designated based on the host species from which they were first isolated and the predominant disease syndrome [1, 9, 13]. The RSIV clade, formally recognized as the species Megalocytivirus pagrus1 by the International Committee on Taxonomy of Viruses (ICTV), represents a highly pathogenic agent of marine and, increasingly, freshwater finfish aquaculture across East Asia and beyond [3, 14, 15]. Understanding the taxonomic hierarchy and the genetic diversity within this species is essential for accurate diagnosis, epidemiological surveillance, and the development of effective prophylactic measures.
Taxonomic Hierarchy and the Megalocytivirus Genus
At the family level, Iridoviridae is characterized by icosahedral virions 120–200 nm in diameter, a linear double-stranded DNA genome of 105–220 kb, and a cytoplasmic replication strategy. RSIV particles range from 140–160 nm, as confirmed by ultrastructural studies of both naturally infected fish tissues and permissive cell lines such as grunt fin (GF) and KF-1 [19, 22]. The genus Megalocytivirus was established to accommodate viruses that induce profound splenic and renal pathology, with histopathological hallmarks including cellular hypertrophy, necrosis, and the presence of IBCs containing massive numbers of virions within intracytoplasmic virus assembly sites [19]. Early classification relied heavily on host range and clinical presentation; however, with the advent of molecular phylogenetics, genotypic delineation based on core genes, particularly the major capsid protein (MCP) and adenosine triphosphatase (ATPase), has become the gold standard [9, 16, 21]. The MCP gene is highly conserved across the genus, enabling broad-spectrum detection by pan-megalocytivirus real-time PCR assays, but it also possesses sufficient variability to differentiate the three major clades: ISKNV, TRBIV, and RSIV [1, 13, 16].
Genotypic Classification and Phylogenetic Lineages
Within the RSIV clade, two distinct genotypes (I and II) have been historically recognized based on phylogenetic analysis of MCP and ATPase sequences [1, 11, 12]. Genotype I is exemplified by the Ehime-1 strain from Japan and the GMIV (golden mandarin fish iridovirus) strain from Korea, while genotype II includes more recent isolates such as KagYT-96, RIE12-1, and the majority of Korean field isolates from rock bream and Asian seabass [15, 16, 21]. Genotype II has been the dominant lineage circulating in Korean aquaculture since the 1990s and is associated with high mortality in rock bream (Oplegnathus fasciatus) and red sea bream (Pagrus major) [4, 10]. In contrast, genotype I has been more prevalent in Japanese red sea bream farms, though contemporary strains have displayed increasing complexity. Whole-genome sequencing of nine isolates from the 2021 outbreaks in Oita and Ehime Prefectures, Japan, revealed a highly uniform genotype II population that originated from a common ancestor genetically distinct from earlier genotype I strains, suggesting a population replacement event [11].
Emergence of Intermediate and Mixed Genotypes
A major advance in RSIV taxonomy has been the identification of “intermediate” or “mixed” genotypes that cannot be unambiguously assigned to either genotype I or II. The 17SbTy isolate, recovered from Japanese seabass (Lateolabrax japonicus) in Korea, was the first to be characterized as a mixed subtype I/II: of its 115 open reading frames (ORFs), 69 were most similar to genotype II (98.48–100% identity), while 46 were closest to genotype I (98.77–100% identity) [21]. This mosaic genome architecture challenges the binary classification scheme and implies that recombination or reassortment may occur in nature. Subsequent studies have shown that the mixed subtype I/II (exemplified by 17SbTy and 17SbTy-related isolates) exhibits significantly lower virulence than pure genotype II (e.g., 17RbGs), with reduced infectivity (ID₅₀), lower cumulative mortality in cohabitation challenge trials, and differential expression of apoptotic regulators such as caspase-8 and caspase-3 [12]. Importantly, a novel intermediate type (designated GT1-Oita2024) was recently detected in Japan for the first time, showing regions of homology to genotype I, genotype II, and even TRBIV [1]. The GT1-Oita2024 strain also harbored mutations in the laminin-type epidermal growth factor-like domain (LEGFD) gene, which encodes the epitope recognized by the monoclonal antibody M10 used in routine immunofluorescence antibody tests (IFAT), leading to false-negative diagnostic results [1, 17]. This discovery underscores the necessity of incorporating genotypic classification into diagnostic algorithm updates, as recommended by the World Organisation for Animal Health (WOAH).
The taxonomic position of the freshwater-adapted RSIV isolates further illustrates the plasticity of this virus. The Megalocyti-KD1201 strain, isolated from cage-cultured spotted mandarin (Siniperca scherzeri) in Dandong, Northeast China, clustered phylogenetically with the Ehime-1 strain (genotype I) but was recovered from a freshwater environment, demonstrating that RSIV can breach ecosystem barriers and adapt to novel hosts [3]. Similarly, the GMIV strain from golden mandarin fish in Korea also belongs to RSIV subgroup I, confirming the ability of genotype I to infect freshwater perciforms [16]. These findings have profound implications for biosecurity: freshwater aquaculture systems, previously considered low-risk for RSIV, must now be monitored rigorously.
Classification Based on Antigenic Determinants
Beyond genotyping, classification based on antigenic properties has direct practical utility for diagnostics and vaccine development. The M10 monoclonal antibody, which recognizes a seven-amino-acid epitope (EYDCPEY) within the LEGFD protein, is a cornerstone of the WOAH-recommended IFAT for RSIV detection [1, 17]. However, as demonstrated by the GT1-Oita2024 intermediate type, mutations in the LEGFD gene can abolish M10 binding, leading to false-negative IFAT results despite confirmed PCR positivity [1]. This phenomenon indicates that antigenic classification does not always align with genotypic classification; indeed, the LEGFD epitope is conserved across many megalocytiviruses, including ISKNV and TRBIV, but variant strains may escape antibody detection [17]. Consequently, diagnostic guidelines must incorporate both molecular and antigenic typing, and the adoption of MCP-targeted PCR assays, validated with high diagnostic sensitivity and specificity, remains critical [2, 9]. The development of a viability quantitative PCR using propidium monoazide further advances the ability to distinguish infectious virions from non-infectious debris, a distinction that conventional PCR cannot make and that is essential for accurate epidemiological risk assessment [6, 8].
Implications for Diagnostic and Vaccination Strategies
The taxonomic complexity of RSIV directly informs disease management. For example, formalin-inactivated vaccines developed against genotype II strains (e.g., 17RbGs) have shown high relative percent survival (approximately 80%) in rock bream, but their efficacy against mixed subtype I/II or intermediate strains remains to be fully characterized [8, 21]. Similarly, the identification of asymptomatic carriers such as black sea bream (Acanthopagrus schlegelii) and flathead grey mullet (Mugil cephalus), species that shed the virus without overt mortality, demands species-specific surveillance and quarantine protocols, particularly in polyculture settings where multiple genotypes may coexist [5, 7]. The WHO and FAO have recognized RSIV as a transboundary aquatic animal pathogen of economic significance, and the WOAH Aquatic Animal Health Code mandates reporting of outbreaks and the use of validated diagnostic tests [2, 18]. As genomic surveillance expands, the taxonomy of Megalocytivirus pagrus1 will likely evolve to include newly discovered recombinants and intermediate lineages, necessitating a dynamic classification framework that integrates whole-genome phylogeny, antigenic profiling, and pathogenic phenotype.
Genomic Characterization and Genetic Diversity of RSIV
The genomic architecture of red sea bream iridovirus (RSIV) reveals a complex and dynamic genetic landscape that underpins its evolutionary potential, host range plasticity, and differential pathogenicity. As a member of the genus Megalocytivirus within the family Iridoviridae, RSIV possesses a large, double-stranded DNA genome ranging from approximately 112 to 113 kilobase pairs, encoding between 114 and 115 open reading frames (ORFs) depending on the isolate [1, 11, 21]. The complete genome sequences of representative Korean isolates 17SbTy (112,360 bp, 115 ORFs) and 17RbGs (112,235 bp, 114 ORFs) have provided foundational insights into the genetic organization and evolutionary relationships of this pathogen [21]. These genomes exhibit a characteristic iridovirus structure, encompassing genes involved in DNA replication, transcription, virion assembly, immune evasion, and host interaction, with the major capsid protein (MCP) and adenosine triphosphatase (ATPase) genes serving as primary phylogenetic markers for genotype assignment [1, 16, 21].
Genotypic Classification and Phylogenetic Framework
The current taxonomic framework for RSIV delineates two principal genotypes, genotype I and genotype II, based on phylogenetic analysis of the MCP and ATPase genes, a system that has been instrumental in tracking viral spread and evolutionary divergence across East Asian aquaculture systems [1, 12, 21]. Genotype I is historically associated with the prototype Ehime-1 strain from red sea bream (Pagrus major) in Japan, while genotype II encompasses more recently circulating isolates from Korea and Japan that have been linked to extensive disease outbreaks in rock bream (Oplegnathus fasciatus) and other susceptible species [11, 16, 21]. However, this binary classification has been complicated by the emergence of isolates displaying mosaic genomic compositions that defy simple genotypic assignment, necessitating a more nuanced understanding of RSIV genetic diversity.
Whole-genome sequencing of RSIV samples collected in Japan during 2024 revealed a paradigm-shifting discovery: the identification of an intermediate-type isolate designated GT1-Oita2024, which represents the first detection of this genotype within Japanese territory [1]. This isolate exhibited a remarkable chimeric genomic architecture, with regions demonstrating high homology to genotype I, genotype II, and even turbot reddish body iridovirus (TRBIV) sequences, indicating that RSIV genotypes are not rigid evolutionary lineages but rather exist along a continuum of genetic exchange [1]. The GT1-Oita2024 isolate showed highest average nucleotide identity (ANI) with the previously characterized SBIV-VP13 and 17SbTy strains, both of which have been described as mixed subtype I/II [1, 21]. Critically, this intermediate-type isolate tested negative using the M10 monoclonal antibody-based immunofluorescent antibody test (IFAT), a standard diagnostic tool in Japan, due to multiple mutations in the LEGFD gene encoding the M10 epitope [1, 17]. This finding has immediate and profound implications for diagnostic surveillance, as reliance on M10-based detection may underestimate the true prevalence and geographic distribution of genetically divergent RSIV strains [1, 2].
Mixed Subtype I/II and the Continuum of Genetic Diversity
The concept of mixed subtype I/II RSIV isolates was initially established through the comprehensive genomic characterization of Korean isolates 17SbTy (from Japanese seabass, Lateolabrax japonicus) and 17RbGs (from rock bream, Oplegnathus fasciatus) [21]. Genomic analysis of 17SbTy revealed a striking bipartite ancestry: 69 of its 115 ORFs were most closely related to subtype II (98.48–100% nucleotide identity), while the remaining 46 ORFs showed closest affinity to subtype I (98.77–100% identity) [21]. This mosaicism suggests that 17SbTy likely arose through recombination events between ancestral genotype I and II lineages, a mechanism that may facilitate rapid adaptation to new host species and environmental conditions [1, 21]. In contrast, the 17RbGs isolate displayed a more homogeneous subtype II genomic signature, consistent with its classification as a canonical genotype II strain [21].
The biological significance of this genetic mosaicism has been elucidated through comparative virulence studies. Experimental infections in rock bream demonstrated that the mixed subtype I/II isolate 17SbTy exhibited significantly lower pathogenicity compared to the subtype II isolate 17RbGs, as evidenced by higher survival rates, reduced viral shedding, and lower odds ratios for splenic pathology [12]. Specifically, the infectious dose 50 (ID₅₀) for 17RbGs was markedly lower than that for 17SbTy using both intraperitoneal injection and bath immersion routes, indicating that genotype II strains are inherently more virulent in this highly susceptible host species [12]. Furthermore, cohabitation challenge experiments revealed that 17SbTy-infected donor fish shed lower quantities of virus into the water column, resulting in reduced transmission efficiency to naïve cohabitants [12]. Transcriptomic analyses of viral gene expression identified two critical insertion/deletion mutations in ORFs 014R (encoding a DNA-binding protein) and 102R (encoding a myristoylated membrane protein) between the two isolates, which may contribute to the observed virulence differential [12, 21]. Notably, expression of caspase-8, a key initiator of caspase-dependent apoptosis, was significantly upregulated in 17RbGs-infected fish at 11 days post-infection, while caspase-3 remained low, suggesting that subtype II viruses may manipulate apoptotic pathways to enhance replication and dissemination [12, 31].
Genomic Determinants of Pathogenicity and Host Adaptation
The RSIV genome encodes a suite of proteins that collectively determine viral fitness, tissue tropism, and host range. The MCP, encoded by ORF006L in reference genomes, is the most abundant structural protein and serves as the primary target for diagnostic assays and vaccine development [9, 26, 27]. Epitope mapping studies using phage display technology have identified the laminin-type epidermal growth factor-like domain (LEGFD) protein as the specific antigen recognized by the widely used M10 monoclonal antibody, with the minimal epitope localized to seven amino acids (EYDCPEY) in the extracellular domain [17]. The presence of this epitope in other megalocytiviruses, including infectious spleen and kidney necrosis virus (ISKNV) and TRBIV, explains the cross-reactivity of M10 antibodies across the genus [17]. However, the emergence of intermediate-type isolates harboring mutations in this critical epitope demonstrates that RSIV can evade antibody-based detection through antigenic variation, a phenomenon with direct consequences for disease surveillance and control programs [1, 17].
Advanced molecular modeling using AlphaFold3 and molecular dynamics simulations has provided unprecedented insight into the structural biology of RSIV-host protein interactions. The MCP was shown to form a stable complex with host heat shock cognate protein 70 (HSC70), with a calculated binding free energy of −318.45 kJ/mol, indicative of a strong and likely functionally significant interaction [27]. The binding interface is stabilized by an extensive hydrogen-bond network, and mutational analysis identified residues 646ILE and 452ILE as critical mediators of complex formation, with hydrogen bonding and van der Waals forces serving as the primary stabilizing forces [27]. This interaction may facilitate viral entry, uncoating, or intracellular trafficking, representing a potential target for antiviral intervention. Additional host interaction partners identified through membrane yeast two-hybrid screening include heat shock proteins Hsc70, HSP90β, and HSC71-like protein, further implicating the host stress response machinery in RSIV pathogenesis [27].
The LEGFD gene, in addition to encoding the M10 epitope, has been demonstrated to play a role in viral replication kinetics and immunomodulation. Transcriptomic analyses of RSIV-infected rock bream spleen revealed that LEGFD was among six viral genes significantly upregulated at 5 days post-injection, coinciding with peak viral replication [29]. The expression of LEGFD and other viral genes, including those encoding RING-finger domain-containing proteins, may contribute to the downregulation of host inflammation-related genes such as granzyme and eosinophil peroxidase, which has been proposed as a mechanism underlying the extreme susceptibility of rock bream to RSIV infection [29]. This immunosuppressive strategy is consistent with observations that RSIV infection in rock bream results in a characteristic downregulation of inflammation-related genes, potentially facilitating unchecked viral replication and high mortality rates [29, 30].
Whole-Genome Epidemiology and Spatiotemporal Dynamics
The application of whole-genome sequencing to RSIV outbreak investigations has revolutionized our understanding of viral transmission networks and evolutionary trajectories. Analysis of nine RSIV isolates collected from Oita and Ehime Prefectures in Japan in 2021 revealed remarkably uniform genome sequences, with no genetic variation attributable to geographic location or host species, suggesting a single introduction event followed by rapid clonal expansion across the region [11]. Phylogenetic comparisons with historical isolates from 2017–2019 demonstrated that the 2021 outbreak strains were genetically distinct from earlier circulating viruses, indicating that the outbreak originated from a common ancestor distinct from previously endemic lineages [11]. Notably, the 2021 isolates harbored specific mutations in protein-coding sequences predicted to be involved in viral pathogenicity and infectivity, although the functional consequences of these mutations remain to be experimentally validated [11].
The first detection of intermediate-type RSIV in Japan in 2024, designated GT1-Oita2024, represents a significant expansion of known viral diversity and raises critical questions regarding the origins and dissemination pathways of chimeric strains [1]. Phylogenetic analysis placed GT1-Oita2024 in a clade with SBIV-VP13 and 17SbTy, both of which were previously identified in Korea [1, 21]. This genetic relatedness across international boundaries suggests that mixed subtype I/II isolates may have been introduced into Japan through anthropogenic activities, such as the movement of infected live fish or fomite-contaminated equipment, rather than through natural dispersion via seawater [1, 23, 28]. The potential for such introductions underscores the importance of biosecurity measures and international cooperation in disease surveillance, as articulated by the World Organisation for Animal Health (WOAH) in its aquatic animal health standards [2, 25].
Genetic Diversity and Host Range Expansion
The genetic plasticity of RSIV is further evidenced by its ability to adapt to and cause disease in an expanding range of host species, including both marine and freshwater fish. The isolation of Megalocyti-KD1201 from cage-cultured spotted mandarin (Siniperca scherzeri) in Northeast China demonstrated that RSIV has breached the environmental barrier between marine and freshwater ecosystems, infecting a host species phylogenetically distant from typical marine victims [3]. Phylogenetic analysis placed Megalocyti-KD1201 within a distinct RSIV clade alongside the Ehime-1 strain, suggesting that this freshwater isolate shares a common ancestry with genotype I viruses from Japanese red sea bream [3]. Similarly, the golden mandarin fish iridovirus (GMIV) strain from Korea, isolated from Siniperca scherzeri during a 2016 outbreak, was classified as RSIV-subgroup I based on MCP and ATPase phylogeny, clustering with Ehime-1 and distinct from circulating subtype II isolates in Korea [16]. These findings collectively indicate that RSIV genotype I and related variants possess intrinsic capacity for freshwater adaptation, a trait with significant implications for disease risk assessment in inland aquaculture systems.
The first report of RSIV in Asian seabass (Lates calcarifer) cultured in open estuarine cages along the west coast of India further expands the known host range and geographic distribution of this pathogen [15]. Sequencing of a 568 bp fragment of the DNA polymerase gene revealed 100% sequence identity with previously reported RSIV sequences, and phylogenetic analysis placed the Indian isolate in a cluster with Korean RSIV isolates, distinct from Japanese strains [15]. This genetic affinity suggests possible epidemiological linkages between South Asian and East Asian aquaculture systems, potentially mediated through international trade in live fish or fishery products, a pathway recognized by both WOAH and the Food and Agriculture Organization (FAO) as a major risk factor for transboundary aquatic animal disease spread [15, 18]. The detection of RSIV in imported frozen mackerel at Indonesian ports, while negative in that specific study, highlights the ongoing risk of viral introduction through seafood trade networks [18].
Genetic Markers for Diagnostic and Surveillance Applications
The genetic diversity of RSIV has necessitated the development and continuous refinement of molecular diagnostic tools capable of detecting all known genotypes with high sensitivity and specificity. TaqMan probe-based real-time PCR assays targeting conserved regions of the MCP gene have demonstrated the ability to amplify RSIV, ISKNV, and TRBIV genotypes, with a 95% limit of detection (LoD₉₅%) as low as 5.3 genome copies per reaction [13] to 10.96 copies per reaction [9]. These assays exhibit diagnostic sensitivity of 100% and specificity exceeding 99% when validated against large field sample sets (n = 510), with excellent inter-operator reproducibility [9]. However, the emergence of intermediate-type isolates with divergent genetic sequences, particularly in genes targeted by PCR primers, may compromise the performance of existing assays and mandates periodic re-evaluation of diagnostic targets [1, 2].
Comparative evaluation of PCR-based methods across different RSIV severity grades (G0–G4) has revealed that nested PCR and modified 1-F/1-R conventional PCR exhibit the highest diagnostic sensitivity, particularly for low-grade infections (G0–G2) characteristic of asymptomatic carriers or early-stage disease [2]. The LoD₉₅% for nested PCR was determined to be 11.23 copies/reaction, while modified 1-F/1-R achieved 51.32 copies/reaction, both substantially lower than the original 1-F/1-R and 4-F/4-R assays [2]. These sensitive methods are essential for detecting RSIV in wild fish populations, which typically harbor low viral loads (10¹.¹ copies/mg DNA) compared to clinically diseased cultured fish (10³.³ copies/mg DNA) [24]. The ability to detect subclinical infections in wild fish, which may serve as incidental reservoirs rather than primary sources of transmission, is crucial for accurate epidemiological risk assessment [5, 24].
The integration of viability qPCR using propidium monoazide (PMAxx) has addressed a critical limitation of conventional PCR, the inability to distinguish infectious virions from non-infectious viral debris or vaccine residues. Treatment with 75 μM PMAxx effectively inhibited amplification of heat-inactivated RSIV while allowing detection of intact, infectious virions, providing a more accurate measure of infection risk in environmental samples [6]. Application of this technology revealed that formalin-inactivated vaccination significantly reduces infectious viral shedding in rock bream, achieving functional sterilization of shedding even in the absence of sterilizing immunity, and that conventional qPCR significantly overestimates the risk posed by vaccinated populations [8]. These findings underscore the importance of adopting viability-based molecular methods for accurate epidemiological monitoring and vaccine efficacy assessment.
Evolutionary Implications and Future Directions
The accumulating evidence from whole-genome sequencing, phylogenetic analyses, and functional genomics paints a picture of RSIV as a genetically dynamic pathogen undergoing rapid evolution in response to selective pressures from host immunity, environmental conditions, and anthropogenic interventions. The discovery of mosaic genomes indicative of recombination between genotype I and II lineages suggests that RSIV possesses a modular genetic architecture that facilitates the exchange of functional gene cassettes, potentially accelerating adaptation to new hosts and environments [1, 21]. The identification of insertions and deletions in genes encoding DNA-binding proteins and membrane-associated proteins that correlate with virulence differences between subtype II and mixed subtype I/II isolates provides specific genetic targets for mechanistic studies of pathogenicity [12, 21].
The divergence in epidemiological roles observed among different RSIV genotypes, with subtype II strains exhibiting high virulence and shedding in susceptible hosts like rock bream, while mixed subtype I/II strains demonstrate attenuated pathogenicity but maintain the capacity for asymptomatic persistence in reservoir species such as black sea bream (Acanthopagrus schlegelii) and flathead grey mullet (Mugil cephalus), has profound implications for disease management [5, 7, 12]. Asymptomatic carriers of intermediate-type RSIV may serve as cryptic reservoirs that sustain viral transmission within and between aquaculture facilities, evading detection by standard diagnostic methods and complicating eradication efforts [1, 5]. The continued surveillance of RSIV genetic diversity, encompassing both symptomatic outbreaks and subclinical infections in wild and cultured fish populations, is therefore essential for anticipating future disease emergence and informing evidence-based control strategies [1, 11, 24].
Molecular Pathogenesis and Antigenic Variation of RSIV
The intricate interplay between Red Sea Bream Iridovirus (RSIV) and its piscine hosts represents a paradigm of viral manipulation, immune evasion, and genetic plasticity. As a member of the genus Megalocytivirus within the family Iridoviridae, RSIV exhibits a complex molecular pathogenesis that is inextricably linked to its capacity for antigenic variation, a feature that confounds diagnostic efforts and vaccine development. Understanding these molecular mechanisms is not merely an academic exercise; it is fundamental to devising robust control strategies for an economically devastating pathogen affecting global aquaculture, as recognized by the World Organisation for Animal Health (WOAH) [1, 2, 14].
Molecular Determinants of Viral Entry and Replication
The initial stages of RSIV infection are governed by the interaction between viral surface proteins and host cellular receptors. The major capsid protein (MCP) is the most abundant structural component and the primary immunogenic target [26, 27]. While the definitive host receptor for RSIV remains unidentified, the MCP is unequivocally the principal architect of cell entry. Using a sophisticated combination of a membrane yeast two-hybrid system and AlphaFold3-based structural prediction, recent work has mapped the molecular interface between the RSIV MCP and the host heat shock cognate protein 70 (HSC70) [27]. This interaction is not incidental; computational analyses demonstrate a remarkably stable complex, stabilized by an extensive hydrogen-bond network and van der Waals forces, yielding a calculated binding free energy of -318.45 kJ/mol [27]. Mutational analysis pinpointed residues 452Ile and 646Ile within the MCP as critical mediators of this interaction, suggesting that these residues are essential docking points for cellular entry [27]. This interaction likely facilitates the internalization of the virus, potentially via clathrin-mediated endocytosis, a pathway commonly hijacked by large DNA viruses.
Once internalized, RSIV replication is a cytoplasmic event, a hallmark of iridoviruses. The virus assembles within intracytoplasmic viral assembly sites (VAS), discernible by electron microscopy as discrete regions within the cytoplasm of infected cells [19, 20]. Ultrastructural studies have revealed a dynamic morphogenesis, progressing from filamentous precursor structures to partially-filled and then fully assembled virions, which are icosahedral, hexagonal particles measuring 145–150 nm in diameter [19, 20]. The virus exhibits a broad cellular tropism in vitro, productively infecting cell lines from grunt fin (GF), koi fin (KF-1), barfin flounder (BF-2), and notably, a newly developed red sea bream brain cell line (RSBB) [22, 35]. However, the GF cell line appears optimal for robust viral replication, yielding the highest titers [22]. This permissiveness is in stark contrast to the resistance observed in epithelial cell lines such as EPC, FHM, and EK-1, highlighting a fundamental, yet molecularly undefined, species- and tissue-specific restriction factor [22].
Antigenic Variation and the Molecular Basis of Immune Evasion
Perhaps the most clinically and epidemiologically significant aspect of RSIV is its capacity for antigenic variation, which has direct implications for both diagnosis and vaccine efficacy. The molecular foundation of this variation is most clearly illuminated by the analysis of the laminin-type epidermal growth factor-like domain (LEGFD) protein. This protein is the primary antigen recognized by the monoclonal antibody M10 (mAb M10), the cornerstone of the immunofluorescence antibody test (IFAT) widely used for rapid RSIV diagnosis in Japan [1, 17]. Through elegant epitope mapping using a phage-display RSIV peptide library, the exact heptapeptide epitope recognized by mAb M10 was identified as EYDCPEY, located within the extracellular domain of the LEGFD protein [17].
This discovery provides a critical molecular lens through which to view emerging antigenic variants. Whole-genome sequencing of an IFAT-negative RSIV sample collected in Oita, Japan in 2024 (GT1-Oita2024) revealed that the legfd gene harbored several critical mutations in the region encoding the mAb M10 epitope [1]. This direct genetic alteration of the dominant antibody-binding site explains the failure of the diagnostic test. Phylogenetically, GT1-Oita2024 was classified as an intermediate type, a mosaic genome that defies simple classification, showing regions of high homology with genotype I, genotype II, and even TRBIV [1]. This is the first detection of such an intermediate genotype in Japan, indicating that antigenic variation is not a static phenomenon but an ongoing, dynamic evolutionary process [1].
This genetic mosaicism is not limited to the LEGFD protein. Analysis of a Korean mixed subtype I/II isolate (17SbTy) and a subtype II isolate (17RbGs) revealed that the 17SbTy genome is a true chimera, with 69 of its 115 ORFs most closely related to subtype II, but 46 ORFs showing highest identity with subtype I [21]. This suggests a historical recombination event, a powerful engine for generating antigenic novelty [12, 21]. Critically, these genomic differences are functionally linked to virulence. In rock bream (Oplegnathus fasciatus), the subtype II isolate (17RbGs) was significantly more infective and virulent than the mixed subtype I/II isolate (17SbTy), as measured by infectious dose (ID₅₀) and cumulative mortality in cohabitation challenges that mimic natural transmission [12]. The odds ratio for splenic index after infection with 17RbGs was 55.00, compared to 19.38 for 17SbTy, underscoring the profound impact of even subtle genetic changes on pathogenic potential [12].
Immunomodulation and Apoptosis: A Dual-Edged Sword
The molecular pathogenesis of RSIV is further defined by its sophisticated manipulation of the host immune response. The virus actively subverts the host's primary antiviral defenses, particularly interferon signaling and inflammatory cascades. Transcriptomic analysis of RSIV-infected rock bream spleen at 3- and 5-days post-infection revealed that the host response is remarkably maladaptive. While interferon-stimulated genes were upregulated, indicating a canonical antiviral response, a broader cluster of inflammation-related genes, including granzyme and eosinophil peroxidase, were significantly downregulated at 3 dpi [29]. This early suppression of the inflammatory response may be a key virulence mechanism, allowing the virus to establish a replicative niche before a robust immune response can be mounted. This is consistent with findings in mandarin fish, where only a small fraction of differentially expressed genes (309 out of 53,040 unigenes) were altered, with over twice as many genes downregulated as upregulated [30]. The complement system, a key first line of defense, is also targeted; while RSIV infection activates complement C1r and C3 transcripts, the response appears modulatory rather than fully protective, suggesting a delicate balance between host defense and viral evasion [34].
The host's attempt to control infection culminates in programmed cell death. RSIV infection is a potent inducer of apoptosis, but the virus appears to exert tight control over this process [31]. Apoptosis proceeds through distinct morphological stages: cell shrinkage and rounding (early), cell enlargement (middle), and formation of apoptotic body-like vesicles (late) [31]. Crucially, this process is caspase-dependent. However, the use of caspase-3 and -6 inhibitors revealed a critical nuance: while they blocked the morphological changes characteristic of the middle and late apoptotic stages, they did not prevent the early cell rounding induced by RSIV [31]. Furthermore, these inhibitors restricted the synthesis of a subset of viral structural proteins, suggesting that caspase activity is not solely a host defense mechanism but is co-opted by the virus to facilitate the completion of its own replication cycle [31]. This is further supported by observations of differential caspase expression between virulent (17RbGs) and less virulent (17SbTy) isolates. Infection with the highly virulent 17RbGs led to significant upregulation of caspase-8, a key initiator of the extrinsic apoptotic pathway, yet caspase-3 expression remained low, a paradoxical combination that may actively suppress the final executioner phase of apoptosis, thereby prolonging the survival of the infected cell and maximizing viral progeny production [12].
Histopathologically, this complex pathogenesis manifests as the formation of inclusion body-bearing cells (IBCs) in target organs, predominantly the spleen and kidney [4, 7, 19]. Ultrastructural analysis distinguishes two types of IBCs: typical IBCs that harbor a distinct VAS with virions, and atypical IBCs that undergo degeneration without productive virus assembly [19]. This heterogeneity within infected tissues underscores the asynchronous nature of viral replication and host response. The degree of histopathological change is highly correlated with viral load, particularly in the spleen, making splenic viral load a reliable indicator of disease severity and a proxy for pathogenicity [4, 7, 10].
Host Range, Tissue Tropism, and the Role of Asymptomatic Carriers
The molecular determinants governing RSIV’s remarkably broad host range, infecting over 30 marine and, increasingly, freshwater species, remain a key area of investigation [15, 16, 25]. While the MCP-host receptor interaction provides a foundation, species-specific variation in innate immunity, particularly the interferon system, likely plays a decisive role. The virus demonstrates a pronounced tissue tropism for the spleen and kidney, which are the primary sites of replication and pathology [4, 7, 19, 29]. Viral load and shedding kinetics are profoundly influenced by water temperature, with optimal replication and transmission occurring at 25°C, while at 15°C, infection may be subclinical or self-limiting [4, 7, 10, 12]. This temperature-dependence is a critical epidemiological factor, explaining the seasonal nature of RSIVD outbreaks during warm-water periods.
The molecular pathogenesis of RSIV is not uniform across host species, leading to distinct epidemiological roles. Japanese sea bass (Lateolabrax japonicus) act as a highly susceptible host, experiencing rapid viral replication, high shedding, and 0% survival [5]. In stark contrast, black sea bream (Acanthopagrus schlegelii) function as an asymptomatic reservoir; they maintain high viral loads and persistent shedding into the environment yet exhibit high survival rates [5]. This divergent outcome is a direct consequence of differential host-pathogen interactions at the molecular level, likely involving species-specific differences in interferon regulatory factor (IRF) expression and the efficiency of the apoptotic machinery. For instance, the expression of PmIRF5 and PmIRF6, key transcription factors in the interferon pathway, is significantly upregulated in the spleen and kidney of red sea bream upon RSIV infection, yet this response is clearly insufficient to clear the virus [36]. Similarly, the induction of interleukin-1β and IL-8, while contributing to an antiviral state in vitro, does not prevent the establishment of lethal infection in vivo [33]. This suggests that RSIV possesses redundant mechanisms to counteract the cytokine-mediated antiviral state. The identification of asymptomatic carriers like black sea bream and broodstock red sea bream is of paramount importance for aquaculture biosecurity, as they represent cryptic sources of viral shedding that can initiate outbreaks in naïve, highly susceptible populations [5, 32].
Epidemiology and Transmission Dynamics in Aquaculture
Red Sea Bream Iridovirus (RSIV) represents one of the most economically significant viral pathogens confronting marine finfish aquaculture across East Asia, with its epidemiology shaped by a complex interplay of host susceptibility, environmental drivers, anthropogenic activities, and viral genetic diversity. The transmission dynamics of RSIV within and between aquaculture facilities are neither stochastic nor uniform; rather, they reflect a highly structured system governed by species-specific shedding kinetics, temperature-dependent replication, fomite-mediated dissemination, and the ecological roles of wild fish reservoirs. Understanding these dynamics at mechanistic depth is prerequisite to designing effective biosecurity interventions, risk assessment frameworks, and surveillance strategies.
Host Range, Reservoir Species, and Asymptomatic Carriers
The epidemiological landscape of RSIV is defined by a remarkably broad host range, the virus has been documented in over 30 marine and freshwater fish species across Asia, including but not limited to red sea bream (Pagrus major), rock bream (Oplegnathus fasciatus), Japanese sea bass (Lateolabrax japonicus), flathead grey mullet (Mugil cephalus), black sea bream (Acanthopagrus schlegelii), spotted mandarin fish (Siniperca scherzeri), and Asian seabass (Lates calcarifer) [3-5, 7, 15, 16]. Critically, however, the epidemiological role of each host species is not equivalent. Recent controlled challenge studies have demonstrated striking divergence in survival outcomes, viral replication kinetics, and shedding patterns across species, revealing a spectrum ranging from highly susceptible amplifiers to asymptomatic reservoirs.
In a systematic comparative analysis, Ji et al. [5] exposed black sea bream (BSB) and Japanese sea bass (JS) to RSIV under identical immersion and cohabitation conditions. Japanese sea bass exhibited 0% survival, with rapid, high-level viral replication and extensive dissemination prior to mortality, a classic amplifier host phenotype. In stark contrast, black sea bream maintained high survival rates despite harboring significant viral loads and, most importantly, persistently shedding infectious virus into the water column without clinical signs. This asymptomatic reservoir capacity has profound epidemiological implications: BSB, which are commonly reared in adjacent net pens or may occur as wild bycatch, can sustain viral circulation undetected, serving as cryptic sources of infection for sympatric highly susceptible species. Similarly, flathead grey mullet have been confirmed as both susceptible to RSIV and capable of horizontal transmission to cohabiting rock bream and red sea bream, with viral shedding peaking immediately before or after mortality events [7]. The presence of such subclinically infected shedders within a farm system means that reliance on clinical signs alone for outbreak detection is fundamentally inadequate.
The role of broodstock as latent carriers has been compellingly documented through long-term environmental DNA (eDNA) surveillance. Kawato et al. [32] conducted three years of monitoring at a red sea bream farm in Japan and demonstrated that asymptomatic broodstock shed RSIV at concentrations exceeding 10⁵ copies/L of seawater, levels sufficient to initiate outbreaks in naïve juveniles housed in separate net pens. Crucially, neither clinical signs nor mortality were observed in the broodstock throughout the monitoring period, yet viral loads in broodstock pen seawater were higher than in juvenile pens just prior to the juvenile outbreak. This finding directly implicates vertically or laterally maintained carrier populations as the proximate source of epizootic ignition, challenging the assumption that disease outbreaks arise de novo from environmental contamination.
Water Temperature as a Master Regulator of Transmission Dynamics
Among abiotic factors, water temperature exerts the most profound influence on RSIV transmission dynamics, modulating viral replication rate, host susceptibility, shedding magnitude, and ultimately, outbreak seasonality. RSIV is characterized as a warm-water pathogen, with epizootics occurring almost exclusively during summer months when seawater temperatures exceed 20°C, peaking between 25°C and 30°C across much of East Asia [10, 11]. Kim et al. [10] conducted a comprehensive kinetic study in rock bream at three temperature regimes (15°C, 20°C, 25°C) and multiple inoculation doses. At 25°C, viral replication was rapid, with maximum shedding into seawater (10³·⁷–10⁶·⁷ RSIV genome copies/L/g) coinciding with peak mortality periods. At 20°C, replication and shedding were delayed and attenuated. At 15°C, no mortality was observed across any experimental group, even though viral genome was detectable in both fish tissues and seawater by qPCR [4, 10]. This temperature-dependent blockade of pathogenesis while permitting low-level viral persistence has critical implications: clinically inapparent infections at suboptimal temperatures can seed viral reservoirs that become fulminantly expressed when temperatures rise.
The experimental manipulation of temperature shifts further illuminates this dynamic. In rock bream infected at 15°C and subsequently subjected to a gradual temperature increase (1°C/day to 25°C), viral replication accelerated sharply, and shedding increased commensurately [10]. Conversely, when temperature was decreased from 25°C to 15°C post-infection, viral replication was initially rapid but then declined after 14 days, suggesting that sustained high temperature is required for full epizootic expression. This temperature sensitivity likely reflects host immunological mechanisms: at permissive temperatures, RSIV actively downregulates inflammation-related genes, including granzyme and eosinophil peroxidase, thereby blunting the host's capacity to control viral replication [29]. At lower temperatures, the host may mount a more effective interferon-mediated response, or viral enzymatic processes may be thermodynamically constrained.
The practical consequence is that RSIV epizootics display a consistent seasonal pattern, with mortality events commencing in late spring, peaking in mid-to-late summer, and subsiding in autumn. This predictability provides an opportunity for timed prophylactic interventions, vaccination schedules, for example, should be completed before water temperatures reach the permissive threshold, but also creates a narrow window during which undetected viral circulation can amplify to outbreak proportions.
Viral Shedding, Waterborne Transmission, and Environmental DNA Surveillance
The horizontal transmission of RSIV occurs predominantly through the waterborne route, with infectious virions shed into seawater primarily from the spleen and kidney of infected fish and subsequently acquired by naïve hosts via the gills or gastrointestinal tract [4, 7]. The kinetics of shedding are tightly linked to disease progression within the host. In rock bream subjected to immersion challenge, viral shedding into seawater peaked 2–3 days before or after the onset of mortality, reaching concentrations as high as 10⁶ copies/L of seawater [7]. The correlation between intra-host viral load and shedding magnitude is robust: Kim et al. [4] demonstrated a significant positive correlation between RSIV copy number in the spleen of rock bream and the concentration of virus detected in ambient water, with the spleen showing the strongest correlation with histopathological grade.
Quantitative understanding of the relationship between seawater viral concentration and infection risk has been advanced through controlled dose-response challenge experiments. Kawato et al. [28] exposed juvenile red sea bream (approximately 10 g) to seawater containing defined RSIV concentrations (10³–10⁷ copies/L) for three days, mimicking natural field exposure. Probit analysis revealed that the inferred infection rate at 10⁵·⁹ copies/L was 50%, whereas at 10³·¹ copies/L, the infection rate dropped to 0.0001%. This nonlinear dose-response relationship implies a threshold effect: below approximately 10⁴ copies/L, the probability of establishing a productive infection is vanishingly small. Critically, three-year surveillance at ten fixed sampling points across multiple farms (n=306 seawater samples) yielded only seven samples exceeding 10⁴ copies/L, and those exclusively originated from net pens experiencing active outbreaks [28]. This finding challenges the assumption that environmental water serves as a continuous, high-risk transmission medium between farms. Instead, RSIV appears to be rapidly diluted by tidal currents, with viral gradients steeply declining within meters of the source net pen [28]. The authors concluded that "seawater can function as a potential wall to reduce the transmission of RSIV" and that biosecurity efforts should focus on interrupting fomite and equipment-mediated pathways.
The development of environmental DNA (eDNA) methods has revolutionized the capacity to monitor RSIV dynamics in situ. Kawato et al. [32] employed an iron-based flocculation coupled with large-pore filtration to concentrate virus from seawater, achieving detection limits sufficient to track viral loads weeks before clinical signs emerged. In their landmark three-year farm study, RSIV was detected in eDNA at least five days before the first observed mortality in juvenile cohorts, providing a critical early warning window. The temporal correlation between eDNA viral load and daily mortality count was striking: during the July 2017 outbreak, when daily mortality exceeded 20,000 fish, eDNA concentrations peaked at 10⁶ copies/L. After depopulation of infected cohorts and removal of 90% of broodstock, eDNA levels fell below 10² copies/L [32]. The discriminatory power of eDNA is further enhanced by viability qPCR methods using propidium monoazide (PMAxx), which selectively amplifies DNA from intact, potentially infectious virions while excluding signals from inactivated virus or degraded nucleic acids [6, 8]. This distinction is critical for accurate risk assessment, as conventional qPCR significantly overestimates infectious risk by detecting non-infectious DNA artifacts, particularly in vaccinated populations where vaccine-derived nucleic acid may persist [8].
Fomite-Mediated Transmission and Biosecurity Implications
While waterborne transmission is the primary natural route, anthropogenic activities, specifically the movement of contaminated equipment and personnel, constitute a potent and potentially preventable transmission mechanism between net pens and farms. This was definitively demonstrated in a case study of a semi-open system aquaculture farm experiencing an RSIV outbreak [23]. Kawato et al. systematically assessed cross-contamination risk and found that equipment used for collecting dead fish, particularly landing nets and gloves, was heavily contaminated with RSIV. When farm operations were restructured so that dead-fish collection began in net pens without disease and proceeded to the outbreak pen, and landing nets were disinfected daily, RSIV transmission to other pens was prevented for over 30 days. However, when the operational order was reversed (starting with the outbreak pen and moving to unaffected pens), RSIV was transmitted to all net pens within approximately one week [23]. This compelling causal evidence identifies contaminated fomites as a high-velocity transmission vector, capable of overcoming the spatial dilution that limits waterborne spread.
The implication for biosecurity is clear: even in semi-open systems where seawater flows freely between pens, equipment hygiene and operational sequencing can effectively block transmission. Disinfection protocols must be rigorously applied to all equipment that contacts fish or water, including nets, gloves, boots, grading equipment, and transport containers. The World Organisation for Animal Health (WOAH) recommends that such fomite management be integrated into national biosecurity standards for RSIV-endemic regions. The practical utility of these measures is reinforced by the finding that RSIV can retain infectivity through multiple freeze-thaw cycles, particularly in the presence of serum, highlighting that even frozen fish products or equipment stored under cold conditions may harbor infectious virus [37].
Genotype-Specific Virulence and Epidemiological Consequences
The epidemiological landscape of RSIV has been further complicated by the recognition of genotypic diversity and its association with differential virulence. RSIV is classified within the genus Megalocytivirus and has historically been divided into genotypes I and II, with genotype II predominating in Korean and Japanese outbreaks [1, 21]. However, the discovery of intermediate or mixed genotype I/II isolates has challenged simple phylogenetic classification and raised questions about the evolutionary trajectory of virulence.
Jeong et al. [12] directly compared the virulence of a genotype II isolate (17RbGs) and a mixed subtype I/II isolate (17SbTy) in rock bream. The genotype II isolate was significantly more infective by both intraperitoneal injection and bath immersion, as determined by infectious dose 50 (ID₅₀). In cohabitation challenges, cumulative mortality was markedly higher in the 17RbGs (genotype II) group, regardless of inoculation dose. The spleen index odds ratio for 17RbGs infection was 55.00, compared to 19.38 for 17SbTy, indicating a substantially elevated risk of splenic pathology [12]. Transcriptomic analysis revealed that viral genes encoding a DNA membrane protein and myristoylated protein, both bearing insertion/deletion mutations distinguishing the two isolates, were significantly upregulated in the more virulent 17RbGs infection. Furthermore, while caspase-8 (an initiator of extrinsic apoptosis) was upregulated at 11 days post-infection in both groups, caspase-3 (an executioner caspase) remained low, suggesting that RSIV actively suppresses apoptotic cell death to sustain viral replication, a mechanism previously described at the cellular level [12, 31]. The mixed subtype I/II isolate appears to represent a less pathogenic lineage, possibly reflecting adaptation to different host species or an evolutionary intermediate that has not yet acquired full virulence determinants.
Whole-genome sequencing of 2021 Japanese isolates revealed further complexity: nine isolates from Oita and Ehime Prefectures exhibited highly uniform sequences, yet were genetically distinct from isolates circulating in the same regions during 2017–2019, suggesting introduction from a common ancestor distinct from previously circulating strains [11]. The 2024 detection of a genotype I/II intermediate type in Japan (GT1-Oita2024), which showed regions homologous to both genotype I and genotype II, as well as TRBIV, and which tested negative by the standard M10 monoclonal antibody-based immunofluorescence test due to mutations in the LEGFD epitope, marks the first identification of this genotype in Japan and raises concerns about diagnostic escape and undetected spread [1, 17]. The LEGFD protein, which harbors the M10 epitope (EYDCPEY), is a critical target for rapid diagnostic testing, and mutations in this region could lead to false-negative results, thereby enabling cryptic transmission [1, 17].
Wild Fish Populations: Source or Sink?
A central epidemiological question is whether wild fish populations serve as a reservoir from which RSIV spills over into aquaculture, or conversely, whether aquaculture operations amplify the virus and spill back into wild stocks. The preponderance of evidence supports the latter scenario. Kawato et al. [24] surveyed 1,102 wild fish representing 44 species captured near aquaculture installations in western Japan over a four-year period. Only 11 fish from 7 species were RSIV-positive by real-time PCR, and their mean viral load (10¹·¹ ± 0.4 copies/mg DNA) was three orders of magnitude lower than that of seemingly healthy red sea bream within net pens during an ongoing outbreak (10³·³ ± 1.5 copies/mg DNA). Sequencing of the major capsid protein gene revealed that the RSIV genome detected in wild fish was identical to that of concurrently diseased farmed fish in the same area. Temporal analysis indicated that RSIV-positive wild fish appeared during or shortly after outbreaks in cultured fish, not before [24]. These data strongly suggest that wild fish acquire RSIV from farm effluents rather than serving as primary sources of introduction. The low viral loads in wild fish imply that they are unlikely to sustain transmission chains or to initiate outbreaks in naïve farms, although the possibility of a low-frequency spillback event cannot be entirely excluded.
Integrated Epidemiological Synthesis
Synthesizing these findings, the transmission dynamics of RSIV in aquaculture can be conceptualized as a multi-route, temperature-gated, species-modulated system. The fundamental transmission cycle begins with a source population, either asymptomatically infected broodstock, chronically infected reservoir species (e.g., black sea bream, flathead grey mullet), or acutely infected amplifier hosts (e.g., Japanese sea bass, rock bream). Infectious virions are shed into seawater from the spleen and kidney, with shedding magnitude proportional to intra-host viral load and histopathological severity [4, 7]. Waterborne transmission is efficient within a net pen but rapidly attenuates with distance due to tidal dilution, such that between-pen transmission via water is limited except at very short distances (<10 m) [28]. The principal mechanism for between-pen and between-farm dissemination is mechanical carriage on contaminated equipment and human vectors [23]. Temperature governs all aspects of this cycle: below 20°C, replication is suppressed, shedding is minimal, and transmission chains are unlikely to be sustained; above 25°C, replication accelerates, shedding intensifies, and epizootics become explosive [10]. The presence of genotypic variants with differential virulence and diagnostic escape potential adds an additional layer of complexity that demands continuous molecular surveillance [1, 11, 12]. Vaccination with formalin-inactivated vaccines can break transmission cycles by reducing viral shedding to sublethal levels, achieving functional sterilization of horizontal transmission even in the absence of sterilizing immunity [8]. However, the reliance on M10 antibody-based diagnostics, which may fail to detect emerging genotypes, underscores the need for molecular confirmation and the adoption of PCR-based methods for both surveillance and import screening [1, 2, 18].
Diagnostic Approaches and Challenges for RSIV Detection
The accurate and timely detection of Red Sea Bream Iridovirus (RSIV) is paramount for implementing effective biosecurity measures, controlling disease outbreaks, and mitigating the substantial economic losses inflicted upon the global aquaculture industry. The diagnostic landscape for RSIV has evolved considerably, moving from classical histopathological observation and virus isolation to a sophisticated array of molecular, serological, and emerging field-deployable technologies. However, each methodological category presents distinct advantages and inherent limitations, particularly when confronted with the virus's genetic diversity, variable tissue tropism, and the complex dynamics of viral shedding in aquatic environments. This section provides an exhaustive analysis of the current diagnostic approaches, their mechanistic underpinnings, and the formidable challenges that persist in achieving reliable, sensitive, and context-appropriate RSIV detection.
Molecular Detection: The Gold Standard and Its Nuances
Molecular assays, particularly polymerase chain reaction (PCR)-based methods, have become the cornerstone of RSIV diagnostics due to their high sensitivity, specificity, and rapid turnaround times. The World Organisation for Animal Health (WOAH) recommends several PCR protocols, and rigorous comparative evaluations have been critical in defining their performance characteristics.
Real-Time Quantitative PCR (qPCR): The development of TaqMan probe-based real-time PCR assays has set a high benchmark for RSIV detection. A seminal study by Kim et al. (2022) validated a qPCR assay targeting the major capsid protein (MCP) gene, demonstrating a 95% limit of detection (LoD95%) of 10.96 copies per reaction and a diagnostic sensitivity (DSe) of 100% and diagnostic specificity (DSp) of 99.60% when tested against 510 field samples [9]. This assay proved robust even in the presence of common PCR inhibitors found in aquaculture settings, such as humic acids and heavy metals, and exhibited high inter-operator reproducibility [9]. Another independently developed TaqMan assay achieved an LoD95% of 5.3 copies/μL, with a DSe of 100% and DSp of 95.2% compared to conventional PCR [13]. These assays are indispensable for quantifying viral loads in tissues and environmental samples, providing critical data for epidemiological studies and vaccine efficacy trials. For instance, qPCR has been instrumental in demonstrating that viral loads in the spleen correlate most strongly with histopathological grades of infection [4, 7] and that viral shedding into seawater peaks just before or after mortality events [4, 7, 10].
Conventional and Nested PCR: While qPCR offers superior quantification, conventional PCR remains a valuable tool, particularly in resource-limited settings. A comprehensive evaluation by Kim et al. (2024) assessed the diagnostic efficacy of WOAH-recommended assays, including the 1-F/1-R and 4-F/4-R conventional PCRs, a modified 1-F/1-R assay, and a nested PCR [2]. The nested PCR exhibited the highest analytical sensitivity, with an LoD95% of 11.23 copies/reaction, closely followed by the modified 1-F/1-R assay at 51.32 copies/reaction [2]. Critically, this study revealed that diagnostic sensitivity varies significantly across different severity grades of infection. For early-stage infections (Grades G0-G2), where viral loads are low and clinical signs are absent, the nested PCR and modified 1-F/1-R assays demonstrated the highest DSe, making them particularly valuable for screening asymptomatic carriers and detecting the virus in subclinical infections [2]. This finding underscores a major challenge: reliance on less sensitive conventional PCRs may lead to false negatives in early or latent infections, allowing the virus to spread undetected.
Challenges in Molecular Detection:
- Genetic Diversity and Primer Mismatch: The emergence of new RSIV genotypes presents a significant challenge to molecular diagnostics. The recent discovery of an "intermediate type" RSIV in Japan (GT1-Oita2024), which harbors regions homologous to genotype I, genotype II, and TRBIV, highlights the potential for primer-template mismatches [1]. This strain was PCR-positive using standard primers but tested negative with the M10 monoclonal antibody-based immunofluorescent antibody test (IFAT), indicating a genetic divergence in the antigenic target [1]. Similarly, the mixed subtype I/II isolates (e.g., 17SbTy) possess unique genomic features, including insertion/deletion mutations in functional protein-coding regions [21]. These mutations could theoretically alter the binding efficiency of primers designed against conserved regions of older isolates, leading to under-quantification or complete failure of detection. Continuous genomic surveillance and periodic re-evaluation of primer and probe sequences are therefore essential to maintain diagnostic accuracy.
- Differentiation of Infectious vs. Non-Infectious Virus: A fundamental limitation of standard qPCR is its inability to discriminate between infectious virions and non-infectious viral nucleic acid from degraded particles, vaccine residues, or dead virus. This is a critical issue for environmental monitoring and post-vaccination assessment. To address this, a propidium monoazide (PMAxx)-based viability qPCR (vqPCR) assay has been developed [6, 8]. PMAxx is a photoactive dye that penetrates damaged viral envelopes or capsids and covalently binds to the viral DNA, thereby inhibiting its amplification by qPCR. This vqPCR assay effectively distinguishes between heat-inactivated and infectious RSIV and has been shown to selectively detect infectious virus in seawater more efficiently than conventional qPCR [6]. In a vaccine efficacy study, conventional qPCR significantly overestimated the viral risk in vaccinated fish by detecting non-infectious DNA artifacts from the formalin-inactivated vaccine, whereas vqPCR provided a more accurate assessment of infectious viral replication and shedding [8]. This technology is crucial for accurate epidemiological risk assessment and for evaluating the true impact of vaccination on viral transmission.
Serological and Immunological Approaches
Serological methods offer a different perspective on RSIV infection, primarily by detecting host antibodies or viral antigens.
Immunofluorescent Antibody Test (IFAT): The IFAT using the anti-RSIV monoclonal antibody M10 (mAb M10) has been a mainstay for rapid diagnosis in Japan. The epitope for mAb M10 has been mapped to a seven-amino-acid sequence (EYDCPEY) located in the extracellular domain of the laminin-type epidermal growth factor-like domain (LEGFD) protein [17]. This test is rapid and can be performed directly on tissue imprints. However, its reliability is now under question due to the emergence of antigenic variants. The GT1-Oita2024 intermediate-type strain was found to harbor several mutations in the LEGFD gene, which likely explains its failure to react with mAb M10 in the IFAT [1]. This finding raises a significant concern: IFAT-based surveillance programs may be missing infections caused by emerging genotypes, leading to an underestimation of disease prevalence and spread.
Recombinant Protein Vaccines and Antibody Detection: The development of recombinant vaccines targeting the MCP has provided tools for studying the humoral immune response. A high-hydrostatic-pressure (HHP) refolded recombinant MCP (HHP–RSIV-rMCP) vaccine induced strong RSIV-specific IgM responses in red sea bream [26]. Interestingly, sera from fish immunized with a commercial formalin-inactivated vaccine showed minimal reactivity to the HHP-refolded MCP but reacted strongly to formalin-treated HHP–RSIV-rMCP [26]. This indicates that the conformation of the antigen is critical for antibody recognition and that different vaccine platforms may induce antibodies targeting different epitopes. This has implications for the development of serological diagnostic tests (e.g., ELISA), which must be designed to detect antibodies against relevant, conformationally intact antigens to accurately assess vaccine-induced immunity or past natural exposure.
Emerging and Field-Deployable Technologies
The need for rapid, on-site diagnostics that do not require sophisticated laboratory infrastructure has driven the development of novel detection platforms.
Cross-Priming Amplification-Based Lateral Flow Assay (CPA-LFA): This isothermal amplification method combined with a lateral flow strip offers a promising solution for field diagnosis. The CPA-LFA developed by Kim et al. (2024) can detect RSIV within 60 minutes at a constant temperature of 60°C, eliminating the need for a thermocycler [25]. The assay demonstrated an LoD95% of 385.76 copies/μL, which is comparable to conventional PCR, and exhibited 100% diagnostic specificity and 94.34% diagnostic sensitivity when validated against qPCR using 210 fish samples [25]. The six false-positive samples identified by CPA-LFA had viral loads below 195.1 copies/μL, indicating a slightly lower sensitivity at very low viral titers [25]. Despite this, the inter-operator reproducibility was perfect (kappa = 1.0), and the assay showed no cross-reactivity with other common fish pathogens [25]. This technology is exceptionally well-suited for surveillance in remote aquaculture sites, enabling rapid decision-making for quarantine and culling.
Environmental DNA (eDNA) Monitoring: The application of eDNA for non-invasive RSIV surveillance represents a paradigm shift in disease management. By concentrating and quantifying viral DNA from seawater, eDNA monitoring can provide a holistic view of viral presence in an entire net pen or farm without the need to sample individual fish. A landmark study by Kawato et al. (2021) demonstrated that eDNA monitoring could detect RSIV in seawater at least five days before an overt disease outbreak in juvenile fish [32]. Furthermore, the study implicated asymptomatically infected broodstock as the source of virus that led to an outbreak in juveniles, as viral loads in broodstock net pens were higher than in juvenile pens just before the outbreak [32]. Subsequent work has refined eDNA methods using iron-based flocculation coupled with large-pore filtration to efficiently capture virus from large volumes of seawater [28]. This approach, combined with spatial mapping (inverse distance weighting), has shown that RSIV is rapidly diluted by tidal currents, with the highest viral loads concentrated at the center of an outbreak net pen [28]. The primary challenge for eDNA is its inability to distinguish between infectious and non-infectious virus, a limitation that can be partially overcome by coupling it with the PMAxx-vqPCR approach [6]. Nonetheless, eDNA is a powerful tool for early warning, identifying high-risk periods, and assessing the effectiveness of biosecurity interventions.
Histopathology and Virus Isolation
Histopathology: The hallmark histopathological lesion of RSIV infection is the presence of enlarged cells, known as inclusion body-bearing cells (IBCs), primarily in the spleen, kidney, and other hematopoietic tissues [19, 20]. Electron microscopy reveals that these IBCs contain intracytoplasmic viral assembly sites (VAS) with hexagonal virions measuring 140-160 nm in diameter [19, 22]. While histopathology is useful for confirming clinical cases and understanding pathogenesis, it lacks the sensitivity for early detection and cannot differentiate RSIV from other megalocytiviruses. The correlation between histopathological grade and viral load, particularly in the spleen, is well-established, providing a semi-quantitative measure of disease severity [4, 7].
Virus Isolation: RSIV can be propagated in several fish cell lines, with grunt fin (GF) cells being the most permissive and widely used [22]. Other susceptible lines include KF-1 (koi fin), BF-2 (barfin flounder), and the recently developed RSBB (red sea bream brain) cell line [22, 35]. Cytopathic effect (CPE) is characterized by cell enlargement and rounding [22]. However, virus isolation is time-consuming (7-14 days), requires specialized cell culture facilities, and is less sensitive than molecular methods. Furthermore, the presence of non-infectious virus or low viral titers in samples from asymptomatic carriers can lead to false negatives. The development of the PMAxx-vqPCR provides a molecular alternative that circumvents the need for cell culture when the goal is to specifically detect infectious virus [6].
Challenges and Future Directions
The diagnostic landscape for RSIV is fraught with challenges that demand continuous innovation.
- Genotype-Specific Detection: The discovery of intermediate and mixed genotypes [1, 21] necessitates a shift from single-target assays to multiplex or pan-genotype approaches. Future diagnostic panels should include primers targeting multiple, conserved genomic regions (e.g., MCP, ATPase, and LEGFD) to ensure detection of all known and emerging variants.
- Standardization and Validation: There is a critical need for international ring trials to standardize qPCR protocols across laboratories. The variability in LoD95% values reported for different assays (e.g., 5.3 vs. 10.96 copies/reaction) [9, 13] highlights the influence of reagents, equipment, and protocols. WOAH guidelines must be updated to incorporate validated assays for new genotypes and to recommend the use of vqPCR for specific applications like environmental monitoring and vaccine evaluation.
- Differentiating Infection from Vaccination (DIVA): With the widespread use of formalin-inactivated vaccines, a DIVA strategy is urgently needed. The finding that formalin-treated MCP is antigenically distinct from native MCP [26] suggests that serological tests based on native, conformationally intact antigens could potentially differentiate vaccinated from naturally infected fish. Alternatively, molecular assays targeting viral genes not present in the inactivated vaccine (e.g., genes involved in replication) could be developed.
- Point-of-Care (POC) Validation: While CPA-LFA shows great promise [25], its performance must be rigorously validated under diverse field conditions (e.g., varying water temperatures, salinity, and sample matrices) and against a wider panel of RSIV genotypes. The development of lyophilized, ready-to-use reagents would further enhance its field applicability.
- Integration of Diagnostic Data: The future of RSIV control lies in the integration of multiple diagnostic modalities. For example, eDNA monitoring could provide an early warning, triggering targeted qPCR testing of sentinel fish, followed by vqPCR to assess the risk of live virus shedding. This tiered approach would optimize resource allocation and enable a more nuanced and effective response to the threat of RSIV.
Viral Stability and Environmental Persistence of RSIV
The capacity of Red Sea Bream Iridovirus (RSIV) to persist outside its piscine host and retain infectivity under various environmental conditions is a critical determinant of its epizootiology, transmission dynamics, and the efficacy of biosecurity measures in aquaculture systems. As a financially devastating pathogen notifiable to the World Organisation for Animal Health (WOAH), understanding the physicochemical parameters that govern RSIV stability, from temperature and salinity to desiccation and the presence of organic matter, is fundamental to developing robust risk mitigation strategies. While RSIV is an enveloped virus and is generally considered less resilient in the environment than non-enveloped viruses, its persistence in the marine milieu, on fomites, and through freeze-thaw cycles presents clear challenges for disease control.
Physical Stability in the Aquatic Environment
The marine environment serves as the primary matrix for RSIV transmission, and the virus’s stability in seawater is modulated by a complex interplay of biotic and abiotic factors. Temperature is arguably the most consequential variable. Empirical evidence from controlled challenge studies demonstrates that RSIV replication and shedding are profoundly temperature-dependent, with optimal stability and infectivity observed at higher water temperatures characteristic of summer epizootics. Kim et al. (2022) systematically demonstrated that rock bream (Oplegnathus fasciatus) infected at 25°C exhibited rapid viral replication and high-level shedding into the surrounding seawater, reaching peak loads of approximately (10^{3.7}) to (10^{6.7}) RSIV genome copies per liter per gram of fish, coinciding with active mortality [10]. In stark contrast, fish housed at 15°C following infection showed no mortality, and the virus was either undetectable or present at substantially lower loads in the water column [4, 7, 10]. This thermal sensitivity was further underscored by experiments where a gradual temperature shift from 25°C to 15°C post-infection led to a marked decrease in viral copy numbers in both fish and seawater after 14 days post-infection (dpi), indicating that cooler temperatures not only suppress replication but may also accelerate viral decay in the external environment [10].
Beyond replication kinetics, the physical integrity of the virion itself is susceptible to thermal stress. Jeong et al. (2025) provided quantitative data on the effect of freeze-thaw cycles, a common stressor during sample storage and processing, on RSIV infectivity. Their work revealed that repeated freeze-thaw cycles (without the cryoprotective presence of serum) substantially reduced the titer of infectious particles [37]. This finding has significant implications for both diagnostic sample handling, where serum should be included to preserve viral integrity, and for understanding the virus’s potential survival in frozen fish products, a concern for transboundary disease spread previously investigated in imported frozen mackerel [18]. The practical outcome is that while RSIV can survive freezing, its infectivity is not absolute and is highly contingent on the presence of stabilizing agents.
Persistence in Seawater and the Role of Environmental DNA (eDNA)
The dynamics of RSIV in open water systems are characterized by rapid dilution and decay, which paradoxically both limits and complicates risk assessment. Intensive field surveillance using eDNA monitoring over a three-year period at a red sea bream farm provided robust evidence that viral loads in seawater were typically low, rarely exceeding (10^{4}) copies per liter, except within the immediate confines of a net pen experiencing an active outbreak, where loads could spike to (10^{6}) copies per liter during peak mortality [28, 32]. Kawato et al. (2023) employed spatial mapping to visualize RSIV dispersion, demonstrating that the virus is rapidly diluted by tidal currents; the epicenter of the outbreak net pen showed the highest concentration, but this quickly diminished with distance from the source [28]. This dilution effect is a critical buffer. Using probit analysis of experimental immersion challenges, the same study established a quantal dose-response relationship: the 50% infection dose for red sea bream was equivalent to seawater containing (10^{5.9}) copies/L, whereas water with a load of (10^{3.1}) copies/L was associated with a vanishingly low infection probability of 0.0001% [28]. Over three years of surveillance across 306 samples, only seven samples exceeded the (10^{4}) copies/L threshold, suggesting that the ambient seawater itself is rarely a direct source of high-level infection unless a fish farm is actively experiencing an outbreak [28]. This conclusion aligns with the observation that wild fish captured near aquaculture installations harbor very low viral loads (mean (10^{1.1} \pm 0.4) copies/mg DNA) compared to clinically affected cultured fish ((10^{3.3} \pm 1.5) copies/mg DNA), and appear to be spill-over recipients rather than maintenance hosts [24].
However, the mere detection of viral nucleic acid via ePCR does not equate to infectious risk. A critical methodological advancement in assessing environmental persistence is the development of a viability quantitative PCR (vqPCR) using propidium monoazide (PMAxx). This dye penetrates damaged viral particles, binds to exposed DNA, and prevents its amplification, thereby allowing differentiation between intact, potentially infectious virions and degraded, non-infectious viral debris [6]. Application of this technique has revealed that conventional qPCR can significantly overestimate the risk posed by environmental water, as a substantial fraction of the detected RSIV DNA originates from inactivated virus [6, 8]. This is particularly relevant for evaluating vaccine efficacy, where non-infectious vaccine residues can produce false-positive signals. Moon et al. (2026) demonstrated that formalin-inactivated vaccination dramatically reduced the shedding of infectious virions into seawater, but not necessarily total viral DNA, underscoring the necessity of using viability assays for accurate epidemiological risk assessment [8].
Fomite-Mediated Persistence and Biosecurity Implications
While seawater rapidly dilutes RSIV, contaminated aquaculture equipment represents a high-risk vector for direct, high-titer viral transfer between net pens. A pivotal case study by Kawato et al. (2025) provided direct field evidence of this phenomenon. During an RSIV outbreak in a semi-open system, equipment used for collecting dead fish, particularly landing nets and gloves, was found to be heavily contaminated with RSIV [23]. The practical consequences were stark: when operators collected dead fish starting from the unaffected net pens and moving to the affected pen, no transmission occurred for over 30 days. However, when the operational sequence was reversed (starting from the outbreak pen), the virus was transmitted to all net pens within approximately one week [23]. This demonstrates that RSIV can persist on fomites for at least a working day and potentially longer, surviving desiccation and exposure to the marine environment on net surfaces.
The stability of RSIV on fomites is not merely a matter of passive survival but is potentiated by the high viral loads shed by moribund fish. Viral shedding into seawater from infected rock bream and flathead grey mullet peaks at (10^{6.0}) RSIV copies/L/g just before or during mortality [7]. This concentrated viral material readily adheres to nets, gloves, and other gear used for carcass removal. The implication for biosecurity is that disinfection protocols must be rigorously applied to equipment at the end of each working day, and operational workflows should be designed to move from low-risk to high-risk zones [23]. These findings are consistent with the broader WOAH guidelines for preventing fomite transmission of aquatic pathogens, which emphasize cleaning and disinfection of equipment as a primary control measure, even in open or semi-open systems where water is freely exchanged.
Role of Asymptomatic Reservoirs and Species-Specific Shedding
The persistence and transmission potential of RSIV are also profoundly shaped by the host species involved. Certain species, such as black sea bream (Acanthopagrus schlegelii), act as effective asymptomatic reservoirs. Despite exhibiting high survival rates, these fish can harbor significant viral loads and persistently shed virus into the environment, thereby maintaining a source of infection for more susceptible sympatric species [5]. Conversely, highly susceptible hosts like Japanese sea bass (Lateolabrax japonicus) experience rapid, high-level replication and mortality, but their infectious window, while intensive, is short-lived [5]. This divergent shedding pattern means that a fish farm containing a mix of resistant and susceptible species may present a sustained risk of environmental contamination from the asymptomatic carriers, a factor that must be considered in multi-species aquaculture zones.
Furthermore, the viral genotype itself influences shedding dynamics and environmental persistence. Jeong et al. (2022) compared the virulence of RSIV subtype II (isolate 17RbGs) and a mixed subtype I/II (isolate 17SbTy). The subtype II isolate was significantly more infective and shed at higher ratios, presenting a greater risk of waterborne transmission [12]. The mixed subtype I/II isolate, while still pathogenic, exhibited lower shedding ratios and virulence, suggesting that genetic determinants within the viral genome, specifically insertion/deletion mutations in DNA membrane and myristoylated protein genes, modulate not only pathogenicity but also the quantity of infectious virus released into the environment [12, 21]. This genetic variability underscores the need for ongoing genomic surveillance, such as that conducted by Yoshimura et al. (2025), to monitor the emergence of novel genotypes with potentially altered environmental stability or shedding profiles [1].
Prevention and Control Strategies for RSIV in Aquaculture
The management of Red Sea Bream Iridoviral Disease (RSIVD) necessitates a multi-faceted, evidence-based approach that integrates rigorous biosecurity protocols, advanced surveillance technologies, strategic vaccination programs, and a profound understanding of viral transmission dynamics and host-pathogen interactions. Given the substantial economic losses inflicted upon the mariculture industry across East Asia, prophylactic measures are paramount, as therapeutic options for viral infections in aquatic species remain exceedingly limited. The following sections delineate the comprehensive strategies currently employed and under development to mitigate the impact of RSIV.
Biosecurity and Physical Containment: Interrupting Transmission Pathways
A cornerstone of RSIV control is the stringent implementation of biosecurity measures designed to interrupt horizontal transmission, the primary mode of viral spread. While RSIV is not zoonotic and poses no threat to human health, its capacity to cause catastrophic mortality in aquaculture systems places it under the purview of the World Organisation for Animal Health (WOAH), which mandates reporting and control efforts.
Fomite Management and Operational Hygiene: Recent case studies have unequivocally demonstrated that aquaculture equipment serves as a potent fomite for RSIV transmission. Investigative work during an outbreak in a semi-open system fish farm revealed that equipment used for collecting dead fish, specifically landing nets and gloves, was highly contaminated with the virus [23]. The implementation of a structured daily operation, where dead fish were collected sequentially starting from non-affected net pens and finishing at the outbreak pen, combined with daily disinfection of equipment, successfully prevented virus transmission to other pens for over 30 days [23]. This finding is critical; it challenges the assumption that waterborne transmission is the dominant threat in semi-open systems and underscores that human-mediated fomite transfer is a primary vector. Consequently, comprehensive hygiene protocols, including the use of dedicated, disinfected equipment for each net pen, footbaths, and changing of protective clothing, are non-negotiable components of an effective control program. The failure of such protocols leads to rapid, catastrophic spread; once an upstream pen experienced an outbreak, transmission to all downstream pens occurred within a week, likely via the sequential collection process [23].
Environmental Water and Spatial Dynamics: The role of environmental water as a transmission vector is nuanced. Epidemiological modeling and field surveillance utilizing environmental DNA (eDNA) have provided a more precise risk assessment. Monitoring at fish farms demonstrated that viral loads in seawater are typically low except within the immediate vicinity of an active outbreak pen [28]. The inverse distance weighting analysis visually confirmed that RSIV is quickly diluted by tidal currents, with viral concentrations decreasing sharply with distance from the source [28]. Experimental infection models corroborated this, showing that the infection risk for naïve red sea bream exposed to seawater containing less than 103 copies/L was extremely low, while the 50% infection rate required a concentration of approximately 105.9 copies/L [28]. These data suggest that while water can function as a vector over short distances, the open sea can act as a diluting "wall," significantly reducing transmission risk between distantly separated farms. Biosecurity measures, therefore, should prioritize preventing point-source contamination within a farm rather than relying solely on the impracticality of sterilizing all incoming water in open systems.
Source Control and Reservoir Management: Identifying and managing viral reservoirs is a critical preventive strategy. Longitudinal eDNA monitoring over three years at a red sea bream farm provided compelling evidence that asymptomatic, persistently infected broodstock were the primary source of RSIV outbreaks in juveniles [32]. Viral loads in broodstock net pens were found to be higher than in juvenile pens just prior to an outbreak, and the complete removal of all infected survivors (juveniles and 90% of broodstocks) resulted in a dramatic reduction of eDNA viral copies to near-undetectable levels the following year [32]. This highlights the necessity of rigorous screening and, in severe cases, depopulation of carrier broodstock populations to break the cycle of annual recurrence. Furthermore, the role of wild fish as reservoirs has been investigated. Surveillance of wild fish near aquaculture sites detected RSIV in several species, but at significantly lower viral loads than in clinically affected farmed fish [24]. Critically, the timing of detection in wild fish coincided with or followed outbreaks in cultured fish, and the viral sequences were identical, strongly suggesting that spillover from aquaculture, rather than spillback from a stable wild reservoir, is the primary dynamic [24]. This indicates that wild populations, while not a negligible risk, are likely not the primary instigators of outbreaks.
Surveillance, Early Detection, and Advanced Diagnostics
The second pillar of RSIV control is the deployment of sensitive, specific, and rapid diagnostic tools to enable early detection and timely intervention. As mandated by WOAH guidelines for notifiable diseases, surveillance programs are essential.
Molecular Diagnostics for Precision: The evolution of polymerase chain reaction (PCR)-based assays has dramatically improved diagnostic capabilities. A comparative evaluation of various WOAH-recommended assays demonstrated that nested PCR and a modified 1-F/1-R conventional PCR assay possess the highest diagnostic sensitivity (DSe), particularly for detecting infections at low severity grades (G0-G2), including asymptomatic carriers [2]. With a 95% limit of detection (LoD95%) of 11.23 and 51.32 copies/reaction, respectively [2], these assays are indispensable for pre-outbreak screening. Real-time quantitative PCR (qPCR) remains the gold standard for quantification, offering a robust LoD95% of 12.02 copies/reaction and a diagnostic specificity of 99.60% in a large-scale field evaluation (n=510), with excellent reproducibility between technicians [9]. These assays target the major capsid protein (MCP) gene and can detect all three megalocytivirus genotypes (RSIV, ISKNV, TRBIV) [9, 13].
Field-Deployable and Viability Assays: A critical advancement for field-level control is the development of a cross-priming amplification-based lateral flow assay (CPA-LFA). This point-of-care tool delivers results within 60 minutes at a constant temperature of 60°C without the need for sophisticated thermal cyclers [25]. The assay demonstrated a diagnostic sensitivity of 94.34% and a specificity of 100% compared to qPCR, with perfect inter-operator reproducibility (kappa=1.0) [25]. Its ability to rapidly identify RSIV in the field allows for immediate quarantine and management decisions. Perhaps more transformative for epidemiological intelligence is the propidium monoazide (PMAxx)-based viability qPCR (vqPCR) assay. Conventional qPCR cannot distinguish between infectious virions and non-infectious viral debris, leading to potential overestimation of risk. The PMAxx dye penetrates damaged or inactive viral particles and binds to their DNA, preventing amplification [6]. This vqPCR method selectively detects only intact, infectious viruses, providing a true assessment of infection risk in seawater samples and farm environments, which is invaluable for validating disinfection protocols and understanding true shedding dynamics [6, 8].
Environmental DNA (eDNA) as a Sentinel System: Proactive monitoring of eDNA from seawater has emerged as a powerful non-invasive surveillance tool. Research has proven that eDNA monitoring can detect RSIV in seawater at least five days before clinical signs and mortality appear in farmed juveniles [32]. This predictive capability provides an invaluable window for intervention, such as early harvest, movement restriction, or administration of immunostimulants. The correlation between eDNA viral load and daily mortality counts is high [32], and eDNA monitoring can trace the spatial dispersion of the virus from an index pen [28]. Implementing routine eDNA sampling at sentinel points within a farm is a recommended strategy for advanced health management.
Vaccination: The Frontline of Immunoprophylaxis
Vaccination is the most effective long-term strategy for reducing mortality and mitigating horizontal transmission. The development and deployment of vaccines against RSIV have been a major research focus, yielding several promising platforms.
Inactivated Whole-Cell Vaccines: Formalin-inactivated vaccines have been commercially available and widely used. Field trials with an inactivated vaccine derived from the Megalocyti-KD1201 strain in cage-cultured spotted mandarin fish achieved >90% protection, compared to <15% survival in non-vaccinated groups during natural outbreaks [3]. This demonstrates profound field efficacy. More recent work using a formalin-inactivated vaccine in rock bream has shown that vaccination not only protects the vaccinated individual, achieving a relative percent survival (RPS) of approximately 80% in immersion challenges, but also functionally sterilizes shedding [8]. By using the PMAxx vqPCR assay, researchers demonstrated that while conventional qPCR showed viral RNA in vaccinated fish, the vqPCR confirmed that the shed material was non-infectious, effectively breaking the chain of horizontal transmission to naïve cohabitants [8]. This is a paradigm-shifting finding, showing that vaccination provides a herd immunity effect by eliminating the infectiousness of survivors.
Recombinant Subunit Vaccines: To address safety concerns and manufacturing consistency associated with inactivated vaccines, recombinant platforms have been developed. The major capsid protein (MCP) is the primary immunogenic target. A groundbreaking study employed high-hydrostatic-pressure (HHP) refolding technology to produce a properly folded, soluble recombinant MCP (HHP–RSIV–rMCP) from E. coli inclusion bodies [26]. This structurally preserved antigen induced a strong, conformation-specific IgM antibody response in red sea bream and significantly enhanced disease resistance [26]. Crucially, the induced antibodies recognized the native viral protein, whereas antibodies from fish immunized with a commercial formalin-inactivated vaccine reacted only to formalin-treated antigen, suggesting the inactivated vaccine may expose different, potentially less protective epitopes [26]. This highlights the importance of antigen conformation in vaccine design. Furthermore, computational biology and protein interaction studies have identified the MCP's interaction with host heat shock protein HSC70 as a critical step in viral pathogenesis, with a calculated binding free energy of -318.45 kJ/mol [27]. Targeting this interface with small-molecule therapeutics or competitive peptide vaccines represents a future frontier for control.
Integrated Species-Specific and Environmental Management
A one-size-fits-all approach is inadequate for RSIV control due to profound differences in host susceptibility and environmental influences on viral kinetics.
Species-Specific Risk Profiling: Different fish species play distinct epidemiological roles, necessitating tailored biosecurity strategies. For instance, black sea bream (Acanthopagrus schlegelii) function as an asymptomatic reservoir, capable of maintaining high viral loads and persistent shedding while exhibiting high survival rates [5]. In contrast, Japanese sea bass (Lateolabrax japonicus) are highly susceptible, experiencing 0% survival with rapid viral replication and heavy shedding prior to mortality [5]. Similarly, flathead grey mullet (Mugil cephalus) are pathogenic hosts that shed high levels of virus into the water, peaking just before or after mortality, posing a significant transmission risk to cohabiting species [4, 7]. The rock bream (Oplegnathus fasciatus) is another highly sensitive sentinel species, showing a strong correlation between splenic viral load and histopathological grade [4, 29]. Understanding these roles is critical; farms co-culturing multiple species must prioritize isolation of known reservoir species (e.g., black sea bream) or manage them as high-risk stocks requiring more stringent vaccination and monitoring.
Thermal Influence on Viral Dynamics and Management: Water temperature is a master regulator of RSIV epizootics. The disease is classically associated with high water temperatures (>25°C), during which mass mortality events occur [4, 10]. Experimental data confirm that at 25°C, rock bream infected with RSIV exhibit rapid viral replication, high shedding into seawater, and 100% mortality [4, 10]. Conversely, at 15°C, infection is largely silent; no mortality is observed in cohabitation challenges, and viral shedding is undetectable after 30 days post-infection [4, 7]. However, the virus is not cleared, it persists at low levels. Critically, if water temperatures are subsequently increased (e.g., 1°C/day up to 25°C), viral replication is reactivated, leading to sudden disease outbreaks [10]. This thermal dependency has two key management implications: first, it provides a potential window for intervention during cooler months (e.g., depopulation of carriers); second, it warns against complacency, as apparently healthy fish at low temperatures can trigger an outbreak with seasonal warming. Vaccination schedules should be timed to ensure peak immunity is achieved before the risky high-temperature season.
Vaccine Strain Matching and Genotypic Diversity: The genetic landscape of RSIV is evolving, with implications for vaccine efficacy. The classification of RSIV into genotype I, genotype II, and the newly identified intermediate type (or mixed subtype I/II) is critical [1, 12, 21]. An emerging intermediate genotype, first detected in Japan in 2024, possesses a mosaic genome with regions homologous to both genotype I and II and even TRBIV [1]. This strain carries mutations in the LEGFD gene, the target of the widely used anti-RSIV monoclonal antibody M10, rendering it undetectable by standard immunofluorescent antibody tests (IFAT) [1, 17]. Furthermore, virulence differences exist between subtypes; the subtype II isolate 17RbGs is significantly more infective and pathogenic than the mixed subtype I/II isolate 17SbTy in rock bream, as measured by infectious dose (ID50) and cohabitation mortality [12, 21]. These studies underscore the necessity of continuous genomic surveillance to ensure that commercial vaccines are matched to the circulating viral strains. A vaccine efficacious against subtype II may offer reduced protection against a genetically distinct intermediate type. The World Organisation for Animal Health (WOAH) and national reference laboratories must update diagnostic primers and vaccine seed stocks accordingly.
In summary, a robust control program for RSIV requires a dynamic, layered strategy: (1) operational biosecurity to break fomite transmission; (2) sensitive molecular surveillance, including eDNA and vqPCR, to provide early warning and true risk assessment; (3) strategic vaccination with validated, strain-matched vaccines that can provide both individual and herd immunity; and (4) farm-specific management that accounts for species-specific host roles and the profound influence of thermal regimes. The integration of these evidence-based strategies offers the best prospect for sustainable control of this devastating pathogen in global aquaculture.
References
[1] Yoshimura K, Furukawa M, Konishi K, Nozaki R, Yoshii K, Harakawa S, et al.. Genomic Characterisation of Red Sea Bream Iridovirus (RSIV) Samples Collected in Japan in 2024 Revealed Genotype II and the First Detection of the Intermediate Type in Japan.. Journal of Fish Diseases. 2025. DOI: https://doi.org/10.1111/jfd.70108
[2] Kim K, Kang G, Woo W, Sohn M, Son H, Kim J, et al.. Evaluation of the diagnostic assays detecting red sea bream iridovirus infection at different severity levels.. Journal of Virological Methods. 2024. DOI: https://doi.org/10.1016/j.jviromet.2024.114901
[3] Zhang W, Dong Y, Weng S, Dong C. Immunological Prevention of an Emerging Red Sea Bream Iridovirus [RSIV] in Cage-Cultured Spotted Mandarin Siniperca Scherzeri in Dandong, Northeast China. Collective Journal of Virology. 2024. DOI: https://doi.org/10.70107/collectjvirol-art0009
[4] Kim K, Kang G, Woo W, Sohn M, Son H, Kwon M, et al.. Impact of Red Sea Bream Iridovirus Infection on Rock Bream (Oplegnathus fasciatus) and Other Fish Species: A Study of Horizontal Transmission. Animals. 2023. DOI: https://doi.org/10.3390/ani13071210
[5] Ji C, Moon S, Kwon M, Kim J, Park C, Kim K. Divergent survival and viral shedding patterns of red sea bream iridovirus in black sea bream and Japanese sea bass. Journal of Fish Biology. 2026. DOI: https://doi.org/10.1111/jfb.70456
[6] Kim K, Kang G, Woo W, Sohn M, Son H, Park C. Development of a Propidium Monoazide-Based Viability Quantitative PCR Assay for Red Sea Bream Iridovirus Detection. International Journal of Molecular Sciences. 2023. DOI: https://doi.org/10.3390/ijms24043426
[7] Kim K, Kang G, Woo W, Sohn M, Son H, Kwon M, et al.. Red Sea Bream Iridovirus Kinetics, Tissue Tropism, and Interspecies Horizontal Transmission in Flathead Grey Mullets (Mugil cephalus). Animals. 2023. DOI: https://doi.org/10.3390/ani13081341
[8] Moon S, Kang G, Roh H, Lee Y, Kim M, Sohn M, et al.. A Formalin‐Inactivated Vaccine Enhances Survival and Mitigates Horizontal Transmission of Red Sea Bream Iridovirus ( RSIV ) in Rock Bream (
Oplegnathus fasciatus
): Insights From Viability Quantitative PCR. Journal of Fish Diseases. 2026. DOI: https://doi.org/10.1111/jfd.70176
[9] Kim K, Choi K, Kang G, Woo W, Sohn M, Son H, et al.. Development and Validation of a Quantitative Polymerase Chain Reaction Assay for the Detection of Red Sea Bream Iridovirus. Fishes. 2022. DOI: https://doi.org/10.3390/fishes7050236
[10] Kim K, Choi K, Joo M, Kang G, Woo W, Sohn M, et al.. Red Sea Bream Iridovirus (RSIV) Kinetics in Rock Bream (Oplegnathus fasciatus) at Various Fish-Rearing Seawater Temperatures. Animals. 2022. DOI: https://doi.org/10.3390/ani12151978
[11] Ishihara H, Harakawa S, Kawakami H, Yoshii K, Murase N, Yamada H, et al.. Whole-genome analysis of red sea bream iridovirus spread in 2021 in Japan provided epidemiological and viral traits insight.. Journal of Fish Diseases. 2022. DOI: https://doi.org/10.1111/jfd.13690
[12] Jeong M, Jeong Y, Kim KI. Virulence difference between red sea bream iridovirus mixed subtype I/II and subtype II and the expression of viral and apoptosis-related genes in infected rock bream (Oplegnathus fasciatus).. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.05.041
[13] Kim G, Kim MJ, Choi HJ, Koo MJ, Kim MJ, Min J, et al.. Evaluation of a novel TaqMan probe-based real-time polymerase chain reaction (PCR) assay for detection and quantitation of red sea bream iridovirus. Fisheries and aquatic sciences. 2021. DOI: https://doi.org/10.47853/fas.2021.e34
[14] . red sea bream iridovirus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.66795
[15] Girisha SK, Puneeth TG, Nithin MS, Kumar B, Ajay S, Vinay T, et al.. Red sea bream iridovirus disease (RSIVD) outbreak in Asian seabass (Lates calcarifer) cultured in open estuarine cages along the west coast of India: First report. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2019.734712
[16] Kim K, Hwang SD, Cho M, Jung S, Kim Y, Jeong HD. A natural infection by the red sea bream iridovirus-type Megalocytivirus in the golden mandarin fish Siniperca scherzeri.. Journal of Fish Diseases. 2018. DOI: https://doi.org/10.1111/jfd.12815
[17] Takano T, Matsuyama T, Kawato Y, Sakai T, Kurita J, Matsuura Y, et al.. Identification of the Epitope Recognized by the Anti-Red Sea Bream Iridovirus (RSIV) Monoclonal Antibody M10 Using a Phage Display RSIV Peptide Library. Gyobyo kenkyu - Fish pathology. 2020. DOI: https://doi.org/10.3147/jsfp.54.83
[18] Semarang M, Novitasari A, Desrina, Agustini T. Detection of The Red Sea Bream Iridovirus (RSIVD) and Quality of Frozen Mackerel (Scomber japonicus) Imported Through the Port of Tanjung Mas Semarang. IOP Conference Series: Earth and Environment. 2019. DOI: https://doi.org/10.1088/1755-1315/246/1/012067
[19] Mahardika K. ELECTRON MICROSCOPIC STUDY ON ENLARGED CELLS OF RED SEA BREAM, Pagrus major INFECTED BY THE RED SEA BREAM IRIDOVIRUS (RSIV, GENUS Megalocytivirus, FAMILY Iridoviridae). . 2009. DOI: https://doi.org/10.15578/iaj.4.1.2009.53-63
[20] Mahardika K, Miyazaki T. ULTRASTRUCTURAL ANALYSIS OF GRUNT FIN (GF) CELLS TREATED WITH RED SEA BREAM IRIDOVIRUS (RSIV; family Iridoviridae, genus Megalocytivirus) IN COMBINATIONS WITH INTERFERONS AND SPLENIC SUBSTANCES. Indonesian Aquaculture Journal. 2010. DOI: https://doi.org/10.15578/IAJ.5.1.2010.19-28
[21] Jeong M, Jeong Y, Kim K. Complete Genome Sequences and Pathogenicity Analysis of Two Red Sea Bream Iridoviruses Isolated from Cultured Fish in Korea. Fishes. 2021. DOI: https://doi.org/10.3390/fishes6040082
[22] Mahardika K, Mastuti I. SUSCEPTIBILITY OF DIFFERENT CELLS TO RED SEA BREAM IRIDOVIRUS (RSIV). Indonesian Aquaculture Journal. 2012. DOI: https://doi.org/10.15578/IAJ.7.1.2012.61-67
[23] Kawato Y, Takada Y, Matsuyama T, Kurobe T, Honryo T, Shirakashi S, et al.. Aquaculture Equipment as a Fomite for Transmission of Red Sea Bream Iridovirus: Insights From a Case Study for Assessing Cross-Contamination.. Journal of Fish Diseases. 2025. DOI: https://doi.org/10.1111/jfd.14103
[24] Kawato Y, Mizuno K, Harakawa S, Takada Y, Yoshihara Y, Kawakami H, et al.. Risk assessment of wild fish as environmental sources of red sea bream iridovirus (RSIV) outbreaks in aquaculture.. Diseases of Aquatic Organisms. 2024. DOI: https://doi.org/10.3354/dao03788
[25] Kim G, Shin D, Choi JY, Choi HD, Min J, Kim K. Rapid Visual Detection of Red Sea Bream Iridovirus Using a Novel Cross-Priming Amplification-Based Lateral Flow Assay.. Journal of Fish Diseases. 2024. DOI: https://doi.org/10.1111/jfd.14073
[26] Sawasaki Y, Harakawa S, Kitamura S, Terawaki N, Zhu Z, Yamada K, et al.. Development of a High-Hydrostatic-Pressure-Treated Recombinant Vaccine Targeting the Major Capsid Protein of Red Sea Bream Iridovirus. International Journal of Molecular Sciences. 2026. DOI: https://doi.org/10.3390/ijms27020675
[27] Chen W, Yu J, He M, Wu H, Qiu D, Zhao C. Insights into red sea bream iridovirus pathogenesis: Unveiling host-pathogen interactions using membrane yeast two-hybrid and molecular dynamics.. Bioorganic chemistry (Print). 2026. DOI: https://doi.org/10.1016/j.bioorg.2026.109547
[28] Kawato Y, Takada Y, Mizuno K, Harakawa S, Yoshihara Y, Nakagawa Y, et al.. Assessing the transmission risk of red sea bream iridovirus (RSIV) in environmental water: insights from fish farms and experimental settings. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.01567-23
[29] Eurlaphan C, Nozaki R, Sano M, Koiwai K, Hirono I, Kondo H. Red sea bream iridovirus infection downregulates inflammation-related genes in the spleen of rock bream (Oplegnathus fasciatus).. Journal of Fish Diseases. 2023. DOI: https://doi.org/10.1111/jfd.13858
[30] Zhang Y, Zhang C, Zhang Z, Sun W, Zhang X, Liu X. Analysis of the transcriptomic profiles of Mandarin fish (Siniperca chuatsi) infected with red sea bream iridovirus (RSIV).. Microbial Pathogenesis. 2022. DOI: https://doi.org/10.1016/j.micpath.2022.105921
[31] Imajoh M, Sugiura H, Oshima S. Morphological changes contribute to apoptotic cell death and are affected by caspase-3 and caspase-6 inhibitors during red sea bream iridovirus permissive replication.. Virology. 2004. DOI: https://doi.org/10.1016/J.VIROL.2004.02.006
[32] Kawato Y, Mekata T, Inada M, Ito T. Application of Environmental DNA for Monitoring Red Sea Bream Iridovirus at a Fish Farm. Microbiology spectrum. 2021. DOI: https://doi.org/10.1128/Spectrum.00796-21
[33] Joo M, Choi K, Kang G, Woo W, Kim K, Sohn M, et al.. Red sea bream interleukin (IL)-1β and IL-8 expression, subcellular localization, and antiviral activity against red sea bream iridovirus (RSIV).. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.07.040
[34] Reza MAN, Mohapatra S, Shimizu S, Kitamura S, Harakawa S, Kawakami H, et al.. Molecular cloning, characterization and expression analysis of complement components in red sea bream (Pagrus major) after Edwardsiella tarda and red sea bream Iridovirus (RSIV) challenge. Fish and Shellfish Immunology. 2018. DOI: https://doi.org/10.1016/j.fsi.2018.08.027
[35] Luo X, Fu X, Zhang M, Liang H, Niu Y, Lin Q, et al.. Development of a New Marine Fish Continuous Cell Line Derived from Brain of Red Sea Bream (Pagrosomus major) and Its Application to Fish Virology and Heavy Metal Toxicology. Animals. 2023. DOI: https://doi.org/10.3390/ani13223524
[36] Kim K, Joo M, Kang G, Woo W, Sohn M, Son H, et al.. Characterization of Red Sea Bream (Pagrus major) Interferon Regulatory Factor 5 and 6 Genes and Their Expression in Response to RSIV Infection. Fishes. 2023. DOI: https://doi.org/10.3390/fishes8020114
[37] Jeong J, Kang G, Kim J, Lee J, Park C, Kim K. Red Sea Bream Iridovirus Stability in Freeze–Thaw Cycles: Quantitative Assays of Infectious Particles. Animals. 2025. DOI: https://doi.org/10.3390/ani15121699